FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092022174> ?p ?o ?g. }

• W3092022174 endingPage "205" @default.
• W3092022174 startingPage "197" @default.
• W3092022174 abstract "Abstract Purpose To characterize the progression in retinopathy severity of different phenotypes of mild nonproliferative diabetic retinopathy (NPDR) in patients with type 2 diabetes. Design and methods Patients with type 2 diabetes and mild NPDR (ETDRS 20 or 35) were followed in a 5-year longitudinal study. Examinations, including color fundus photography (CFP) and optical coherence tomography (OCT and OCTA), were performed at baseline, 6 months and then annually. Phenotype classification was performed based on microaneurysm turnover (MAT, on CFP) and central retinal thickness (CRT, on OCT). Phenotype A is characterized by low MAT (< 6) and normal CRT; Phenotype B by low MAT (< 6) and increased CRT; and Phenotype C by higher MAT (≥ 6) with or without increased CRT. ETDRS grading of seven fields CFP was performed at the initial and last visits. Results Analysis of ETDRS grade step changes showed significant differences in diabetic retinopathy (DR) progression between the different phenotypes ( p < 0.001). Of the 66 participants with phenotype A only 2 eyes (3%) presented 2-or-more-step worsening. None of the 50 participants characterized as phenotype B developed 2-step worsening, whereas 13 eyes (23.2%) characterized as phenotype C had 2-or-more-steps worsening. Phenotype C presents the higher risk for 2-or-more step worsening (OR: 15.94 95% CI: 3.45–73.71; p < 0.001) and higher sensitivity, correctly identifying 86.7% of cases at risk (AUC: 0.84 95% CI: 0.72–0.96; p < 0.001). Diabetic retinopathy severity progression was associated with HbA 1c ( p = 0.019), LDL levels ( p = 0.043), and ocular factors as MAT ( p = 0.010), MA formation rate ( p = 0.014) and MA disappearance rate ( p = 0.005). Capillary closure at 5-year follow-up, identified by lower vessel density (VD) on OCTA, was also associated with diabetic DR severity progression ( p = 0.035). Conclusions Different DR phenotypes in type 2 diabetes show different risks of retinopathy progression. Phenotype C is associated with increased HbA 1c values and presents a higher risk of a 2-or-more-step worsening of the ETDRS severity score." @default.
• W3092022174 created "2020-10-15" @default.
• W3092022174 creator A5009200015 @default.
• W3092022174 creator A5009339524 @default.
• W3092022174 creator A5013381773 @default.
• W3092022174 creator A5017440565 @default.
• W3092022174 creator A5036842091 @default.
• W3092022174 creator A5076515187 @default.
• W3092022174 creator A5080311725 @default.
• W3092022174 creator A5086597403 @default.
• W3092022174 date "2020-10-06" @default.
• W3092022174 modified "2023-10-18" @default.
• W3092022174 title "Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression" @default.
• W3092022174 cites W1971041643 @default.
• W3092022174 cites W1979830748 @default.
• W3092022174 cites W1982390886 @default.
• W3092022174 cites W2061080968 @default.
• W3092022174 cites W2074324837 @default.
• W3092022174 cites W2100730679 @default.
• W3092022174 cites W2105468266 @default.
• W3092022174 cites W2127322315 @default.
• W3092022174 cites W2148883078 @default.
• W3092022174 cites W2169961704 @default.
• W3092022174 cites W2201159490 @default.
• W3092022174 cites W2571393191 @default.
• W3092022174 cites W2594336900 @default.
• W3092022174 cites W2597124360 @default.
• W3092022174 cites W2793030983 @default.
• W3092022174 cites W2902050377 @default.
• W3092022174 cites W2944372562 @default.
• W3092022174 cites W3012486655 @default.
• W3092022174 cites W3025989829 @default.
• W3092022174 cites W4212897015 @default.
• W3092022174 cites W4240531687 @default.
• W3092022174 cites W4366807479 @default.
• W3092022174 cites W4530686 @default.
• W3092022174 doi "https://doi.org/10.1007/s00592-020-01602-9" @default.
• W3092022174 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7889686" @default.
• W3092022174 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33025221" @default.
• W3092022174 hasPublicationYear "2020" @default.
• W3092022174 type Work @default.
• W3092022174 sameAs 3092022174 @default.
• W3092022174 citedByCount "14" @default.
• W3092022174 countsByYear W30920221742021 @default.
• W3092022174 countsByYear W30920221742022 @default.
• W3092022174 countsByYear W30920221742023 @default.
• W3092022174 crossrefType "journal-article" @default.
• W3092022174 hasAuthorship W3092022174A5009200015 @default.
• W3092022174 hasAuthorship W3092022174A5009339524 @default.
• W3092022174 hasAuthorship W3092022174A5013381773 @default.
• W3092022174 hasAuthorship W3092022174A5017440565 @default.
• W3092022174 hasAuthorship W3092022174A5036842091 @default.
• W3092022174 hasAuthorship W3092022174A5076515187 @default.
• W3092022174 hasAuthorship W3092022174A5080311725 @default.
• W3092022174 hasAuthorship W3092022174A5086597403 @default.
• W3092022174 hasBestOaLocation W30920221741 @default.
• W3092022174 hasConcept C104317684 @default.
• W3092022174 hasConcept C118487528 @default.
• W3092022174 hasConcept C126322002 @default.
• W3092022174 hasConcept C127716648 @default.
• W3092022174 hasConcept C134018914 @default.
• W3092022174 hasConcept C2776391266 @default.
• W3092022174 hasConcept C2776474195 @default.
• W3092022174 hasConcept C2777180221 @default.
• W3092022174 hasConcept C2778313320 @default.
• W3092022174 hasConcept C2779829184 @default.
• W3092022174 hasConcept C2780248432 @default.
• W3092022174 hasConcept C2780827179 @default.
• W3092022174 hasConcept C55493867 @default.
• W3092022174 hasConcept C555293320 @default.
• W3092022174 hasConcept C71924100 @default.
• W3092022174 hasConcept C86803240 @default.
• W3092022174 hasConceptScore W3092022174C104317684 @default.
• W3092022174 hasConceptScore W3092022174C118487528 @default.
• W3092022174 hasConceptScore W3092022174C126322002 @default.
• W3092022174 hasConceptScore W3092022174C127716648 @default.
• W3092022174 hasConceptScore W3092022174C134018914 @default.
• W3092022174 hasConceptScore W3092022174C2776391266 @default.
• W3092022174 hasConceptScore W3092022174C2776474195 @default.
• W3092022174 hasConceptScore W3092022174C2777180221 @default.
• W3092022174 hasConceptScore W3092022174C2778313320 @default.
• W3092022174 hasConceptScore W3092022174C2779829184 @default.
• W3092022174 hasConceptScore W3092022174C2780248432 @default.
• W3092022174 hasConceptScore W3092022174C2780827179 @default.
• W3092022174 hasConceptScore W3092022174C55493867 @default.
• W3092022174 hasConceptScore W3092022174C555293320 @default.
• W3092022174 hasConceptScore W3092022174C71924100 @default.
• W3092022174 hasConceptScore W3092022174C86803240 @default.
• W3092022174 hasIssue "2" @default.
• W3092022174 hasLocation W30920221741 @default.
• W3092022174 hasLocation W30920221742 @default.
• W3092022174 hasOpenAccess W3092022174 @default.
• W3092022174 hasPrimaryLocation W30920221741 @default.
• W3092022174 hasRelatedWork W2040583314 @default.
• W3092022174 hasRelatedWork W2053503839 @default.
• W3092022174 hasRelatedWork W2379713359 @default.
• W3092022174 hasRelatedWork W2389548857 @default.
• W3092022174 hasRelatedWork W3031492198 @default.

• next